z-logo
Premium
Functional roles of CSPG 4/ NG 2 in chondrosarcoma
Author(s) -
Jamil Nuor S. M.,
Azfer Asim,
Worrell Harrison,
Salter Donald M.
Publication year - 2016
Publication title -
international journal of experimental pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.671
H-Index - 72
eISSN - 1365-2613
pISSN - 0959-9673
DOI - 10.1111/iep.12189
Subject(s) - chondrosarcoma , aggrecanase , cancer research , biology , chemistry , microbiology and biotechnology , medicine , pathology , osteoarthritis , alternative medicine , articular cartilage
Summary CSPG 4/ NG 2 is a multifunctional transmembrane protein with limited distribution in adult tissues including articular cartilage. The purpose of this study was to investigate the possible roles of CSPG 4/ NG 2 in chondrosarcomas and to establish whether this molecule may have potential for targeted therapy. Stable knock‐down of CSPG 4/ NG 2 in the JJ 012 chondrosarcoma cell line by sh RNA resulted in decreased cell proliferation and migration as well as a decrease in gene expression of the MMP (matrix metalloproteinase) 3 protease and ADAMTS 4 (aggrecanase). Chondrosarcoma cells in which CSPG 4/ NG 2 was knocked down were more sensitive to doxorubicin than wild‐type cells. The results indicate that CSPG 4/ NG 2 has roles in regulating chondrosarcoma cell function in relation to growth, spread and resistance to chemotherapy and that anti‐ CSPG 4/ NG 2 therapies may have potential in the treatment of surgically unresectable chondrosarcoma.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom